2018 DEFINITIVE PROXY

Company

LEXICON PHARMACEUTICALS, INC.

Filed

March 16, 2018

Period of Report

March 16, 2018

Accession Number

0001062822-18-000012

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →